PRODUCT MONOGRAPH
PRODUCT MONOGRAPH Pr WELLBUTRIN ... aware that symptoms may persist beyond the discontinuation of bupropion, and clinical management should be provided accordingly. In post-market experience, there have been reports of hypersensitivity reactions in
Download PRODUCT MONOGRAPH
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
PRESCRIBING INFORMATION CYANOCOBALAMIN INJECTION, …
pdf.hres.caSupplied: Each ml contains: Cyanocobalamin 1,000 mcg, Sodium Acetate 0.5 mg, Glacial Acetic Acid 0.1 mg, Sodium Chloride 9.0 mg with Benzyl Alcohol 1.5 % as preservative in Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid may have been used to adjust pH . Multiple dose vials of 10 ml and 30mL.
FLUZONE High-Dose Quadrivalent
pdf.hres.casodium chloride solution. - traces of formaldehyde and ovalbumin. ... Quadrivalent does not contain latex (natural rubber). ... (Split Virion)] is a sterile aqueous suspension of inactivated influenza virus for intramuscular injection.
FLUZONE Quadrivalent
pdf.hres.caSanofi Pasteur Product Monograph 450/477 - FLUZONE® Quadrivalent Page 4 of 35 FLUZONE® Quadrivalent Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration: Intramuscular injection. Dosage Form/Strength: Suspension for injection.
PRODUCT MONOGRAPH
pdf.hres.caPRODUCT MONOGRAPH DUKORAL® Oral, Inactivated Cholera and ETEC Diarrhea Vaccine Oral Suspension Active Immunizing Agent for the Prevention of Diarrhea Caused by Vibrio cholerae and/or heat-labile toxin producing Enterotoxigenic Escherichia coli ATC Code: J07AE01 Manufactured by: Date of Approval: Valneva Sweden AB,
PRODUCT MONOGRAPH INCLUDING PATIENT …
pdf.hres.caAFLURIA® TETRA (Inactivated Influenza Vaccine (Split Virion)) Product Monograph Page 1 of 24 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION AFLURIA® TETRA Quadrivalent Inactivated Influenza Vaccine (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07BB02 2020 - 2021 Strains:
Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Product monograph including patient medication information
PRODUCT MONOGRAPH
pdf.hres.ca8.4 Post Market Adverse Reactions Table updated to as per the ... is a biosimilar biologic drug (biosimilar) to HERCEPTIN®. PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS Indications have been granted on the basis of similarity between OGIVRI and the reference biologic drug ... OGIVRI (trastuzumab) can result in the development of ...
doses of 0.3 mL) Active Immunizing Agent Mainz, Rhineland ...
pdf.hres.cacomirnaty (covid-19 vaccine, mrna) product monograph page 2 of 53 recent major label changes 1. indications 11/2021 4. dosage and administration 11/2021 7. warnings and precautions 11/2021 table of contents
PRODUCT MONOGRAPH GRAVOL
pdf.hres.caEar/Nose/Throat Dimenhydrinate may mask the presence of underlying organic abnormalities or the toxic effects of certain antibiotics and other drugs, particularly those drugs causing ototoxicity. Endocrine and Metabolism Use with caution in patients who are poor CYP2D6 metabolizers and in patients with thyroid dysfunction. Gastrointestinal
ENGERIX-B
pdf.hres.caPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by all known subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga Road
Information, Product, Patients, Monographs, Medication, Including, Engerix, Product monograph including patient medication information engerix
FLULAVAL TETRA (2021-2022)
pdf.hres.caEgg proteins, sodium deoxycholate, ethanol, formaldehyde, sucrose, -tocopheryl hydrogen succinate, polysorbate 80. Thimerosal preservative in the multidose presentation only. For a complete listing see Dosage Forms, Composition and Packaging section. *The prefilled syringe presentation is not available for the 2021- 2 season DESCRIPTION
Related documents
Product Discontinuation Notice - Hikvision
www.hikvision.comproduct line. iVMS-4200 Client Software covers all the functions of iVMS-4200 VS Client Software. Therefore, in order to improve the efficiency and provide better service to our customers, HIKVISION will discontinue iVMS-4200 VS Client Software from January 31, 2021. Discontinued Product Information: Series Name Date of Discontinuation
Product Discontinuation Notice for Intel® WiDi and Intel ...
downloadmirror.intel.comProduct Discontinuation Notice for Intel® WiDi and Intel® Pro WiDi Intel has discontinued marketing and development for Intel® Wireless Display (Intel® WiDi) and Intel® Pro Wireless Display (Intel® Pro WiDi) applications and related …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - …
www.ema.europa.euconcomitant elevations were reversible with prompt discontinuation of tolvaptan, they represent a potential for significant liver injury. Similar changes with other medicinal products have been associated with the potential to cause irreversible and potentially life …
Product, Summary, Characteristics, Discontinuation, Summary of product characteristics
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - Europa
www.ema.europa.euManagement of some adverse reactions may require dose interruption, adjustment, or discontinuation of lenvatinib therapy. Mild to moderate adverse reactions (e.g., Grade 1 or 2) generally do not warrant interruption of lenvatinib, unless intolerable to the patient despite optimal management. For lenvatinib-related toxicities, see Table 4.
Discontinuation of Phyllocontin® (aminophylline) 225mg …
www.ncl-mon.nhs.ukMemo re discontinuation of Phyllocontin® (aminophylline) 225mg and 350mg modified release tablets Page . 2. of . 3. Switching medications . The following advice should be used to support switching to Uniphyllin Continus® (oral theophylline tablets) in patients for whom treatment with a methylxanthine is still required